Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3)
Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers. - page 3, paragraph 3 under the 'Interventions' sec...
Autores Principales: | Villar, Juan Carlos, Herrera, Víctor Mauricio, Carreño, Juan Guillermo Pérez, Herrera, Eliana Váquiro, Domínguez, Yeny Zulay Castellanos, Vásquez, Skarlet Marcell, Cucunubá, Zulma Milena, Prado, Nilda Graciela, Hernández, Yolanda |
---|---|
Formato: | Otro (Other) |
Lenguaje: | Inglés (English) |
Publicado: |
BioMed Central Ltd.
2019
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/23395 https://doi.org/10.1186/s13063-019-3630-y |
Ejemplares similares
-
Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial
por: Villar, Juan Carlos, et al.
Publicado: (2019) -
Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (vol 20, 431, 2019)
por: Carlos Villar, Juan, et al.
Publicado: (2019) -
"Mini Trial"
por: Barajas Arbeláez, Deysi Gineth, et al.
Publicado: (2015-04-14) -
Humanity, on trial Our contributions to the pandemic
por: Martínez Agüero, María
Publicado: (2022) -
Case of the Office of the Prosecutor c. Hassan Habib Merhi, Trial Chamber, decision to conduct the trial in absencia, 20 december 2013
por: López Velásquez, María Paula
Publicado: (2014)